cetylpyridinium chloride anhydrous has been researched along with Debility in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Charlier, P; Jouault, T | 1 |
| Haran, JP; McCormick, BA | 1 |
| Bétry, C; Galan, P; Grenet, G; Hercberg, S; Kesse-Guyot, E; Laville, M; Meugnier, E; Pflieger, M; Vidal, H | 1 |
3 other study(ies) available for cetylpyridinium chloride anhydrous and Debility
| Article | Year |
|---|---|
[A word from the coordinators].
Topics: Aging; Cellular Senescence; Death; Frailty; Health; Humans; Longevity; Research; Skin Aging | 2020 |
Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.
Topics: Aged; Aging; Animals; Disease Models, Animal; Dysbiosis; Frailty; Gastrointestinal Microbiome; Health; Host Microbial Interactions; Human Development; Humans | 2021 |
High expression of CPT1b in skeletal muscle in metabolically healthy older subjects.
Topics: Aged; Aging; Body Composition; Carnitine O-Palmitoyltransferase; Case-Control Studies; Cohort Studies; Female; Frail Elderly; Frailty; France; Health; Healthy Volunteers; Humans; Male; Middle Aged; Muscle, Skeletal; Up-Regulation | 2019 |